<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">PONE-D-12-36088</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0059946</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Neuroscience</subject>
            <subj-group>
              <subject>Neuropsychology</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Diagnostic medicine</subject>
          </subj-group>
          <subj-group>
            <subject>Mental health</subject>
            <subj-group>
              <subject>Psychology</subject>
              <subj-group>
                <subject>Neuropsychology</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Neurology</subject>
            <subj-group>
              <subject>Cerebrovascular diseases</subject>
              <subj-group>
                <subject>Hemorrhagic stroke</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Dementia</subject>
              <subj-group>
                <subject>Vascular dementia</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Cognitive neurology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Surgery</subject>
            <subj-group>
              <subject>Neurosurgery</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Social and behavioral sciences</subject>
          <subj-group>
            <subject>Psychology</subject>
            <subj-group>
              <subject>Neuropsychology</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Mental Health</subject>
          <subject>Surgery</subject>
          <subject>Neuroscience</subject>
          <subject>Neurological Disorders</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Comparison of Montreal Cognitive Assessment and Mini-Mental State Examination in Evaluating Cognitive Domain Deficit Following Aneurysmal Subarachnoid Haemorrhage</article-title>
        <alt-title alt-title-type="running-head">MoCA and MMSE in aSAH</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wong</surname>
            <given-names>George Kwok Chu</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Lam</surname>
            <given-names>Sandy Wai</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wong</surname>
            <given-names>Adrian</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Ngai</surname>
            <given-names>Karine</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Poon</surname>
            <given-names>Wai Sang</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Mok</surname>
            <given-names>Vincent</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <addr-line>Division of Neurosurgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China</addr-line>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <addr-line>Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China</addr-line>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <addr-line>Department of Psychological Studies, The Hong Kong Institute of Education, Hong Kong, China</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Brucki</surname>
            <given-names>Sonia</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>University Of São Paulo, Brazil</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">georgewong@surgery.cuhk.edu.hk</email></corresp>
        <fn fn-type="conflict">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
        <fn fn-type="con">
          <p>Study supervision: WSP GKCW. Conceived and designed the experiments: GKCW AW VM. Performed the experiments: SWL KN AW. Analyzed the data: GKCW. Contributed reagents/materials/analysis tools: GKW SWL KN. Wrote the paper: GKCW.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>3</day>
        <month>4</month>
        <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <issue>4</issue>
      <elocation-id>e59946</elocation-id>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>11</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>2</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Wong et al</copyright-holder>
        <license xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Objective</title>
          <p>Cognitive deficits are common after aneurysmal subarachnoid haemorrhage (aSAH), and clinical evaluation is important for their management. Our hypothesis was that the Montreal Cognitive Assessment (MoCa) is superior to the Mini-Mental State Examination (MMSE) in screening for cognitive domain deficit in aSAH patients.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>We carried out a prospective observational and diagnostic accuracy study on Hong Kong aSAH patients aged 21 to 75 years who had been admitted within 96 hours of ictus. The domain-specific neuropsychological assessment battery, the MoCA and MMSE were administered 2–4 weeks and 1 year after ictus. A cognitive domain deficit was defined as a cognitive domain z score &lt;−1.65 (below the fifth percentile). Cognitive impairment was defined as two or more cognitive domain deficits. The study is registered at ClinicalTrials.gov of the US National Institutes of Health (NCT01038193).</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Both the MoCA and the MMSE were successful in differentiating between patients with and without cognitive domain deficits and cognitive impairment at both assessment periods. At 1 year post-ictus, the MoCA produced higher area under the curve scores for cognitive impairment than the MMSE (MoCA, 0.92; 95% CI, 0.83 to 0.97 versus MMSE, 0.77; 95% CI, 0.66 to 0.83, p = 0.009).</p>
        </sec>
        <sec>
          <title>Interpretation</title>
          <p>Cognitive domain deficits and cognitive impairment in patients with aSAH can be screened with the MoCA in both the subacute and chronic phases.</p>
        </sec>
      </abstract>
      <funding-group>
        <funding-statement>These authors have no support or funding to report.</funding-statement>
      </funding-group>
      <counts>
        <page-count count="7"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Although aneurysmal subarachnoid haemorrhage (aSAH) accounts for only 3% of strokes, its profound consequences and unique window for intervention justify its classification as a separate entity <xref ref-type="bibr" rid="pone.0059946-Chau1">[1]</xref>. Estimated independence in activities of daily living varies between 36% and 60% after aSAH <xref ref-type="bibr" rid="pone.0059946-Rinkel1">[2]</xref>, <xref ref-type="bibr" rid="pone.0059946-AlKhindi1">[3]</xref>, and patients exhibit varying degrees of cognitive dysfunction <xref ref-type="bibr" rid="pone.0059946-Wong1">[4]</xref>, <xref ref-type="bibr" rid="pone.0059946-Wong2">[5]</xref>, <xref ref-type="bibr" rid="pone.0059946-Schweizer1">[6]</xref>. Identifying cognitive dysfunction in aSAH patients is of paramount importance in patient management (i.e. medical treatment, cognitive rehabilitation and social arrangements).</p>
      <p>A systematic review of aSAH cognitive dysfunction showed the main cognitive domain impairments to include memory, executive function and language, the prevalence of which ranges from 0% to 76% <xref ref-type="bibr" rid="pone.0059946-AlKhindi1">[3]</xref>, <xref ref-type="bibr" rid="pone.0059946-Mayer1">[7]</xref>. The most common cognitive screening assessment tool used in neurosurgical clinics is the Mini-Mental State Examination (MMSE), which is quick (5–10 min) and easy to administer in a clinic setting. However, the MMSE was originally designed to screen for Alzheimer’s disease, and thus does not encompass all of the cognitive deficits that might occur following a stroke. It is particularly weak in its ability to measure executive functions, such as abstract thinking, judgment, problem solving and perception, all of which are relevant to the type of dementia associated with vascular disease. More recently, the Montreal Cognitive Assessment (MoCA) has also been used to screening for poststroke cognitive impairment <xref ref-type="bibr" rid="pone.0059946-Pendlebury1">[8]</xref>. The MoCA places greater emphasis on frontal executive function and attention tasks than does the more commonly used MMSE, and it may be more sensitive for the detection of non-Alzheimer’s disease dementia <xref ref-type="bibr" rid="pone.0059946-Nasreddine1">[9]</xref>, <xref ref-type="bibr" rid="pone.0059946-Zadikoff1">[10]</xref>. Dong et al. further extended MoCA’s application during acute admission to predict vascular cognitive impairment 3–6 months after stroke <xref ref-type="bibr" rid="pone.0059946-Dong1">[11]</xref>. Schweizer et al. subsequently found that when applied to 32 aSAH patients at a mean time of 29 months after aSAH, the MoCA was more sensitive to specific neurocognitive test scores than the MMSE, although they did not assess cognitive domain deficits <xref ref-type="bibr" rid="pone.0059946-Schweizer1">[6]</xref>. The MoCA has also been shown to correlate with functional outcomes in aSAH patients at 3 months <xref ref-type="bibr" rid="pone.0059946-Wong3">[12]</xref>. Godefroy et al., however, found that as a screening assessment for cognitive impairment, MoCA was not superior to MMSE with adjusted cut-off scores in subacute stroke patients <xref ref-type="bibr" rid="pone.0059946-Godefroy1">[13]</xref>.</p>
      <p>Clinical disability and handicap scales are insensitive to poor neuropsychological outcomes. Accordingly, there is a well-recognised need to develop tests that are sensitive to the subtle but disabling effects of aSAH. The objective of the study reported herein was to collect additional data on evaluations of post-aSAH cognitive impairment and the theoretical advantages of using the MoCA in aSAH patients. Accordingly, we assessed the diagnostic accuracy of MoCA scores relative to the more commonly used MMSE scores in detecting post-aSAH cognitive impairment in the subacute and chronic phases of aSAH (i.e. 2–4 weeks and 1 year after ictus).</p>
    </sec>
    <sec id="s2" sec-type="methods">
      <title>Methods</title>
      <p>This prospective observational four-centre study was carried out in Hong Kong. It is registered at ClinicalTrials.gov of the US National Institutes of Health (NCT01038193), and was approved by the Joint CUHK-NTEC Clinical Research Ethics Committee. It conformed to the Declaration of Helsinki, and written informed consent was obtained from all of the participants or their next of kin.</p>
      <p>The patient inclusion criteria were: 1) spontaneous subarachnoid haemorrhage with angiography-confirmed aetiology of intracranial aneurysms; 2) hospital admission within 96 hours of ictus; 3) between 21 and 75 years of age; 4) speaker of Chinese (Cantonese); and 5) willing and able to provide informed consent (or availability of a person authorised to do so). The exclusion criteria were: a) a history of previous cerebrovascular or neurological disease other than unruptured intracranial aneurysm; b) a history of neurosurgery before ictus; and c) inability to cooperate in cognitive assessments (unable to obey commands).</p>
      <p>Assessments were conducted 2–4 weeks (subacute phase) and 1 year (chronic phase) after ictus by one of two research assistants (psychology graduates) trained by a post-doctoral research psychologist. The cognitive assessments were carried out in a single session or in two sessions on consecutive days. The MMSE was administered before the cognitive domain-specific neuropsychological tests and the MoCA.</p>
      <sec id="s2a">
        <title>Montreal Cognitive Assessment</title>
        <p>The MoCA <xref ref-type="bibr" rid="pone.0059946-Nasreddine1">[9]</xref>, <xref ref-type="bibr" rid="pone.0059946-Wong3">[12]</xref> is a one-page, 30-point test that usually takes 15 minutes or less to administer and includes six subtests: visuospatial/executive functions, naming, attention, abstraction, recall and orientation <xref ref-type="bibr" rid="pone.0059946-Nasreddine1">[9]</xref>, <xref ref-type="bibr" rid="pone.0059946-Wong3">[12]</xref>. One point is added for participants with less than 12 years of education. The cut-off for mild cognitive impairment is 24/25 <xref ref-type="bibr" rid="pone.0059946-Nasreddine1">[9]</xref>. We recently reported the application of the Hong Kong version of MoCA in aSAH and neurosurgical patients following traumatic and spontaneous intracerebral haemorrhage <xref ref-type="bibr" rid="pone.0059946-Wong3">[12]</xref>, <xref ref-type="bibr" rid="pone.0059946-Wong4">[14]</xref>.</p>
      </sec>
      <sec id="s2b">
        <title>Mini-Mental State Examination Chinese (Cantonese) Version</title>
        <p>The MMSE <xref ref-type="bibr" rid="pone.0059946-Crum1">[15]</xref> comprises seven sections (naming, orientation, registration, attention and calculation, recall, praxia, and language). Its maximum total score is 30, and the test can usually be completed in 10 minutes or less. The Cantonese version has been validated in a population of dementia patients, for whom the optimal cut-off was 19/20 <xref ref-type="bibr" rid="pone.0059946-Chiu1">[16]</xref>.</p>
        <p>The battery of cognitive assessments used in this study was previously applied in a local Chinese population <xref ref-type="bibr" rid="pone.0059946-Wong5">[17]</xref>. Its selection was based on (a) its efficacy in previous cognitive studies in local Chinese patients and standard cognitive tests validated in a Cantonese-speaking population, and (b) its balanced range of tests covering verbal and visuospatial memory, attention and working memory, executive functions, psychomotor speed and language. This battery included the following.</p>
      </sec>
      <sec id="s2c">
        <title>Verbal Memory Domain</title>
        <sec id="s2c1">
          <title>i.) Hong Kong List Learning Test (HKLLT) <xref ref-type="bibr" rid="pone.0059946-Chan1">[18]</xref></title>
          <p>The HKLLT is based on the California Verbal Learning Test, which is regularly used in vascular cognitive impairment studies. It is a verbal learning and memory test that consists of two 16-word lists with three learning trials: immediate recall, 10-minute delayed recall and 30-minute delayed recall and recognition. The HKLLT has been validated in both normal and pathological local populations <xref ref-type="bibr" rid="pone.0059946-Chan1">[18]</xref>.</p>
        </sec>
      </sec>
      <sec id="s2d">
        <title>Visuospatial Skill and Memory Domain</title>
        <sec id="s2d1">
          <title>i.) The Rey Osterrieth Complex Figure Test</title>
          <p>The Rey Osterrieth Complex Figure Test is commonly used to assess visuospatial construction skills and visuospatial memory <xref ref-type="bibr" rid="pone.0059946-Wechsler1">[19]</xref>.</p>
        </sec>
      </sec>
      <sec id="s2e">
        <title>Attention and Working Memory Domain</title>
        <sec id="s2e1">
          <title>i.) The verbal and visual digit span forward and backward tests from the Chinese Wechsler Memory Scale-Third Edition <xref ref-type="bibr" rid="pone.0059946-Rey1">[20]</xref> are used to evaluate simple attention and working memory</title>
          <p>Verbal and visual spans have been used as donor scales for composite psychometric measures.</p>
        </sec>
      </sec>
      <sec id="s2f">
        <title>Executive Function and Psychomotor Speed Domain</title>
        <sec id="s2f1">
          <title>i.) Symbol-Digit Modalities Test <xref ref-type="bibr" rid="pone.0059946-Smith1">[21]</xref></title>
          <p>This brief, easy-to-administer, timed coding test is a variant of the Digit-Symbol Coding Task in the Wechsler Adult Intelligence Scale-Third Edition.</p>
        </sec>
        <sec id="s2f2">
          <title>ii.) Color Trails Test (CTT)</title>
          <p>This test originates from the Trail Making Test (TMT), which is used in the timed assessment of psychomotor speed and executive functions. As it features coloured numbers rather than the English alphabet, the CTT is considered to be an acceptable cultural substitute for the original TMT and has been shown to have similar psychometric properties <xref ref-type="bibr" rid="pone.0059946-Lee1">[22]</xref>.</p>
        </sec>
        <sec id="s2f3">
          <title>iii.) Animal fluency</title>
          <p>This test requires subjects to generate as many animal names as possible in one minute. It is a simple timed test that measures both speed and activation and such executive processes as clustering, set-shifting and retrieval <xref ref-type="bibr" rid="pone.0059946-Chan1">[18]</xref>, <xref ref-type="bibr" rid="pone.0059946-Chan2">[23]</xref>.</p>
        </sec>
      </sec>
      <sec id="s2g">
        <title>Language Domain</title>
        <sec id="s2g1">
          <title>i.) modified Boston Naming Test (mBNT) <xref ref-type="bibr" rid="pone.0059946-Tham1">[24]</xref></title>
          <p>The Boston Naming Test is the most frequently used confrontation naming test in assessing language. In this study, we used the mBNT, a validated modified version that contains 15 stimuli appropriate for use in Chinese cultures <xref ref-type="bibr" rid="pone.0059946-Chan1">[18]</xref>.</p>
          <p>Cognitive domain scores were computed by averaging the z scores of the respective test measures derived from established age- and education-matched norms. A cognitive domain deficit was defined as a cognitive domain z score &lt;−1.65 (below the fifth percentile). Cognitive impairment was defined as two or more cognitive domain deficits <xref ref-type="bibr" rid="pone.0059946-Scott1">[25]</xref>.</p>
        </sec>
      </sec>
      <sec id="s2h">
        <title>Statistical Analysis</title>
        <p>Statistical analyses were generated using SPSS for Windows Version 15.0 (SPSS Inc., Chicago, IL, USA) and MedCalc Version 12.2.1.0. Categorical data are presented herein as numbers (percentages) and numerical data as medians and interquartile ranges (IQR), unless otherwise specified. In the assessments of cognitive impairment, a difference with a P value of less than 0.05 was regarded as statistically significant. For the secondary analyses of individual domain deficits, a difference with a P value of less than 0.01 (to account for multiple comparisons) was regarded as statistically significant.</p>
        <p>Receiver operating characteristic (ROC) curves were constructed to examine the ability to distinguish post-aSAH cognitive impairment and the five individual domain deficits (the verbal memory, visuospatial skill and memory, attention and working memory, executive function and psychomotor speed, and language domains) at both 2–4 weeks and 1 year. The area under the curve (AUC) was calculated for each of the aforementioned ROC curves with a 95% confidence interval (95% CI). The AUC represents the probability that the score of a normal sample will be higher than that of an abnormal sample when one sample is drawn from a truly normal population and the other from a truly abnormal population. The statistical significances of the differences between the correspondingly paired MoCA and MMSE AUCs of cognitive impairment and the five individual domain deficits were then assessed using the nonparametric approach adopted by Delong et al. <xref ref-type="bibr" rid="pone.0059946-DeLong1">[26]</xref>. For the MoCA and MMSE ROC curves for cognitive impairment at 2–4 weeks and 1 year, cut-off values were derived at the ROC coordinate points, where both sensitivity and specificity were optimised using the maximised Youden Index (J) <xref ref-type="bibr" rid="pone.0059946-Fluss1">[27]</xref>. The Youden Index is defined as sensitivity (true positive)+specificity (true negative) –1 <xref ref-type="bibr" rid="pone.0059946-Youden1">[28]</xref>. Complete separation of the marker values for abnormal and normal populations results in J = 1, whereas their complete overlap produces 0. The discriminant indices (sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy [% correctly classified]) of cognitive impairment at the optimal cut-offs were calculated for MoCA and the MMSE at the two assessment points.</p>
        <p>The reproducibility of the assessments was not assessed because it was not the focus of the study, and would have been impractical considering the study’s design (possible rehearsal effects and additional inconvenience to patients and their families).</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <p>Seventy-four and 80 patients completed all of the cognitive assessments at 2–4 weeks and 1 year, respectively. The patient profiles are presented in <xref ref-type="table" rid="pone-0059946-t001">Tables 1</xref> and <xref ref-type="table" rid="pone-0059946-t002">2</xref>. No adverse events were reported in relation to the assessments.</p>
      <table-wrap id="pone-0059946-t001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0059946.t001</object-id>
        <label>Table 1</label>
        <caption>
          <title>Patient profile.</title>
        </caption>
        <alternatives>
          <graphic id="pone-0059946-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059946.t001" xlink:type="simple"/>
          <table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Patients completing assessment at 2–4 weeks</td>
                <td align="left" rowspan="1" colspan="1">Patients completing assessments at 1 year</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">(n = 74)</td>
                <td align="left" rowspan="1" colspan="1">(n = 80)</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Age, median (IQR)</td>
                <td align="left" rowspan="1" colspan="1">58(49–66)</td>
                <td align="left" rowspan="1" colspan="1">52(47–61)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Female (%)</td>
                <td align="left" rowspan="1" colspan="1">50(68)</td>
                <td align="left" rowspan="1" colspan="1">55(69)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Hypertension (%)</td>
                <td align="left" rowspan="1" colspan="1">27(37)</td>
                <td align="left" rowspan="1" colspan="1">27(34)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Smoker (%)</td>
                <td align="left" rowspan="1" colspan="1">26(35)</td>
                <td align="left" rowspan="1" colspan="1">22(28)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">WFNS Grade</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">I</td>
                <td align="left" rowspan="1" colspan="1">48(65)</td>
                <td align="left" rowspan="1" colspan="1">45(56)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">II</td>
                <td align="left" rowspan="1" colspan="1">15(20)</td>
                <td align="left" rowspan="1" colspan="1">21(26)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">III</td>
                <td align="left" rowspan="1" colspan="1">4(5)</td>
                <td align="left" rowspan="1" colspan="1">1(1)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">IV</td>
                <td align="left" rowspan="1" colspan="1">6(8)</td>
                <td align="left" rowspan="1" colspan="1">9(12)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">V</td>
                <td align="left" rowspan="1" colspan="1">1(1)</td>
                <td align="left" rowspan="1" colspan="1">4(5)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Location of aneurysm</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">ICA other than PComA</td>
                <td align="left" rowspan="1" colspan="1">11(15)</td>
                <td align="left" rowspan="1" colspan="1">16(20)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PComA</td>
                <td align="left" rowspan="1" colspan="1">13(18)</td>
                <td align="left" rowspan="1" colspan="1">16(20)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Anterior cerebral artery</td>
                <td align="left" rowspan="1" colspan="1">24(32)</td>
                <td align="left" rowspan="1" colspan="1">26(33)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Middle cerebral artery</td>
                <td align="left" rowspan="1" colspan="1">18(24)</td>
                <td align="left" rowspan="1" colspan="1">20(25)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Posterior circulation</td>
                <td align="left" rowspan="1" colspan="1">8(11)</td>
                <td align="left" rowspan="1" colspan="1">12(15)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Aneurysm treatment</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Coiling</td>
                <td align="left" rowspan="1" colspan="1">36(49)</td>
                <td align="left" rowspan="1" colspan="1">43(54)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Clipping</td>
                <td align="left" rowspan="1" colspan="1">38(51)</td>
                <td align="left" rowspan="1" colspan="1">27(46)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Delayed cerebral Infarction</td>
                <td align="left" rowspan="1" colspan="1">3(4)</td>
                <td align="left" rowspan="1" colspan="1">10(13)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Clinical deterioration due to DCI</td>
                <td align="left" rowspan="1" colspan="1">10(14)</td>
                <td align="left" rowspan="1" colspan="1">7(9)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">mRS</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">0</td>
                <td align="left" rowspan="1" colspan="1">9(12)</td>
                <td align="left" rowspan="1" colspan="1">22(28)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">1</td>
                <td align="left" rowspan="1" colspan="1">4(5)</td>
                <td align="left" rowspan="1" colspan="1">12(15)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">2</td>
                <td align="left" rowspan="1" colspan="1">28(38)</td>
                <td align="left" rowspan="1" colspan="1">33(41)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">3</td>
                <td align="left" rowspan="1" colspan="1">15(20)</td>
                <td align="left" rowspan="1" colspan="1">11(14)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">4</td>
                <td align="left" rowspan="1" colspan="1">17(23)</td>
                <td align="left" rowspan="1" colspan="1">1(1)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">5</td>
                <td align="left" rowspan="1" colspan="1">1(1)</td>
                <td align="left" rowspan="1" colspan="1">1(1)</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="nt101">
            <label/>
            <p>ICA: internal carotid artery; PComA: posterior communicating artery; DCI: delayed cerebral ischemia; mRS: modified Rankin Scale; WFNS: World Federation of Neurosurgical Societies.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="pone-0059946-t002" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0059946.t002</object-id>
        <label>Table 2</label>
        <caption>
          <title>Neuropsychological profile of subacute and chronic phase participants.</title>
        </caption>
        <alternatives>
          <graphic id="pone-0059946-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059946.t002" xlink:type="simple"/>
          <table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Patients completing assessments at 2–4 weeks</td>
                <td align="left" rowspan="1" colspan="1">Patients completing assessments at 1 year</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">B (n = 74)</td>
                <td align="left" rowspan="1" colspan="1">C (n = 80)</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Cognitive impairment</td>
                <td align="left" rowspan="1" colspan="1">12(16%)</td>
                <td align="left" rowspan="1" colspan="1">12(15%)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
                  <italic>Cognitive domain deficit</italic>
                </td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Verbal memory</td>
                <td align="left" rowspan="1" colspan="1">12(16%)</td>
                <td align="left" rowspan="1" colspan="1">6(8%)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Visuospatial skill and memory</td>
                <td align="left" rowspan="1" colspan="1">16(22%)</td>
                <td align="left" rowspan="1" colspan="1">13(16%)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Attention and working memory</td>
                <td align="left" rowspan="1" colspan="1">4(5%)</td>
                <td align="left" rowspan="1" colspan="1">6(6%)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Executive function and psychomotor speed</td>
                <td align="left" rowspan="1" colspan="1">14(19%)</td>
                <td align="left" rowspan="1" colspan="1">11(14%)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Language</td>
                <td align="left" rowspan="1" colspan="1">6(8%)</td>
                <td align="left" rowspan="1" colspan="1">7(9%)</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
      <p><xref ref-type="table" rid="pone-0059946-t003">Table 3</xref> shows that both the MoCA and the MMSE were able to differentiate between patients with and without cognitive domain deficits and cognitive impairment. At 2–4 weeks, the two screening methods produced similar AUCs for both cognitive domain deficits and cognitive impairment (<xref ref-type="table" rid="pone-0059946-t004">Table 4</xref> and <xref ref-type="fig" rid="pone-0059946-g001">Figure 1</xref>). At 1 year, the MoCA achieved significantly higher AUCs than the MMSE for cognitive impairment, although not for single domain deficits (<xref ref-type="table" rid="pone-0059946-t005">Table 5</xref> and <xref ref-type="fig" rid="pone-0059946-g002">Figure 2</xref>).</p>
      <fig id="pone-0059946-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0059946.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Receiver operating characteristic curves of cognitive impairment at 2–4 weeks.</title>
        </caption>
        <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059946.g001" position="float" xlink:type="simple"/>
      </fig>
      <fig id="pone-0059946-g002" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0059946.g002</object-id>
        <label>Figure 2</label>
        <caption>
          <title>Receiver operating characteristic curves of cognitive impairment at 1 year.</title>
        </caption>
        <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059946.g002" position="float" xlink:type="simple"/>
      </fig>
      <table-wrap id="pone-0059946-t003" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0059946.t003</object-id>
        <label>Table 3</label>
        <caption>
          <title>Discriminant indices of the Montreal Cognitive Assessment and Mini-Mental State Examination in detecting cognitive impairment.</title>
        </caption>
        <alternatives>
          <graphic id="pone-0059946-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059946.t003" xlink:type="simple"/>
          <table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Cuff-off value</td>
                <td align="left" rowspan="1" colspan="1">Sen (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">Spec (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">PPV (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">NPV (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">Diagnostic Accuracy</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">At 2–4 weeks</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MoCA</td>
                <td align="left" rowspan="1" colspan="1">17/18</td>
                <td align="left" rowspan="1" colspan="1">75(43–95)</td>
                <td align="left" rowspan="1" colspan="1">95(87–99)</td>
                <td align="left" rowspan="1" colspan="1">75(41–95)</td>
                <td align="left" rowspan="1" colspan="1">95(87–99)</td>
                <td align="left" rowspan="1" colspan="1">92%</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MMSE</td>
                <td align="left" rowspan="1" colspan="1">23/24</td>
                <td align="left" rowspan="1" colspan="1">75(43–95)</td>
                <td align="left" rowspan="1" colspan="1">90(80–96)</td>
                <td align="left" rowspan="1" colspan="1">60(32–84)</td>
                <td align="left" rowspan="1" colspan="1">95(86–99)</td>
                <td align="left" rowspan="1" colspan="1">88%</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">At 1 year</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MoCA</td>
                <td align="left" rowspan="1" colspan="1">21/22</td>
                <td align="left" rowspan="1" colspan="1">100(74–100)</td>
                <td align="left" rowspan="1" colspan="1">75(63–85)</td>
                <td align="left" rowspan="1" colspan="1">41(24–61)</td>
                <td align="left" rowspan="1" colspan="1">100(93–100)</td>
                <td align="left" rowspan="1" colspan="1">85%</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MMSE</td>
                <td align="left" rowspan="1" colspan="1">23/24</td>
                <td align="left" rowspan="1" colspan="1">58(28–85)</td>
                <td align="left" rowspan="1" colspan="1">84(73–92)</td>
                <td align="left" rowspan="1" colspan="1">39(17–64)</td>
                <td align="left" rowspan="1" colspan="1">92(82–97)</td>
                <td align="left" rowspan="1" colspan="1">80%</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="nt102">
            <label/>
            <p>Sen: Sensitivity; Spec: Specificity; PPV: Positive Predictive Value; NPV: Negative Predictive Value.</p>
          </fn>
          <fn id="nt103">
            <label/>
            <p>MoCA: Montreal Cognitive Assessment.</p>
          </fn>
          <fn id="nt104">
            <label/>
            <p>MMSE: Mini-Mental State Examination.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="pone-0059946-t004" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0059946.t004</object-id>
        <label>Table 4</label>
        <caption>
          <title>Areas under the curve (AUCs) for the Mini-Mental State Examination and Montreal Cognitive State Examination in assessing cognitive deficits at 2–4 weeks.</title>
        </caption>
        <alternatives>
          <graphic id="pone-0059946-t004-4" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059946.t004" xlink:type="simple"/>
          <table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">MMSE</td>
                <td align="left" rowspan="1" colspan="1">MoCA</td>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">AUC (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">AUC (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">P-value</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Cognitive impairment</td>
                <td align="left" rowspan="1" colspan="1">0.86 (0.75–0.93)</td>
                <td align="left" rowspan="1" colspan="1">0.91 (0.83–0.97)</td>
                <td align="left" rowspan="1" colspan="1">0.324</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Executive function and psychomotor speed</td>
                <td align="left" rowspan="1" colspan="1">0.76 (0.65–0.86)</td>
                <td align="left" rowspan="1" colspan="1">0.81 (0.71–0.90)</td>
                <td align="left" rowspan="1" colspan="1">0.384</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Verbal memory</td>
                <td align="left" rowspan="1" colspan="1">0.62 (0.50–0.73)</td>
                <td align="left" rowspan="1" colspan="1">0.68 (0.56–0.78)</td>
                <td align="left" rowspan="1" colspan="1">0.389</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Visuospatial memory and skill</td>
                <td align="left" rowspan="1" colspan="1">0.84 (0.74–0.92)</td>
                <td align="left" rowspan="1" colspan="1">0.90 (0.80–0.96)</td>
                <td align="left" rowspan="1" colspan="1">0.291</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Attention and working memory</td>
                <td align="left" rowspan="1" colspan="1">0.97 (0.89–0.99)</td>
                <td align="left" rowspan="1" colspan="1">0.88 (0.78–0.94)</td>
                <td align="left" rowspan="1" colspan="1">0.349</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Language</td>
                <td align="left" rowspan="1" colspan="1">0.96 (0.88–0.99)</td>
                <td align="left" rowspan="1" colspan="1">0.97 (0.90–1.00)</td>
                <td align="left" rowspan="1" colspan="1">0.535</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="nt105">
            <label>*</label>
            <p>P&lt;0.05;</p>
          </fn>
          <fn id="nt106">
            <label>**</label>
            <p>P&lt;0.01.</p>
          </fn>
          <fn id="nt107">
            <label/>
            <p>AUC: Area under curve.</p>
          </fn>
          <fn id="nt108">
            <label/>
            <p>MMSE: Mini-Mental State Examination.</p>
          </fn>
          <fn id="nt109">
            <label/>
            <p>MoCA: Montreal Cognitive Assessment.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="pone-0059946-t005" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0059946.t005</object-id>
        <label>Table 5</label>
        <caption>
          <title>Areas under the curve (AUCs) for the Mini-Mental State Examination and Montreal Cognitive State Examination in assessing cognitive deficits at 1 year.</title>
        </caption>
        <alternatives>
          <graphic id="pone-0059946-t005-5" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059946.t005" xlink:type="simple"/>
          <table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">MMSE</td>
                <td align="left" rowspan="1" colspan="1">MoCA</td>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">AUC (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">AUC (95% CI)</td>
                <td align="left" rowspan="1" colspan="1">P-value</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Cognitive impairment</td>
                <td align="left" rowspan="1" colspan="1">0.77 (0.66–0.83)</td>
                <td align="left" rowspan="1" colspan="1">0.92 (0.83–0.97)</td>
                <td align="left" rowspan="1" colspan="1">0.009<xref ref-type="table-fn" rid="nt111">**</xref></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Executive function and psychomotor speed</td>
                <td align="left" rowspan="1" colspan="1">0.74 (0.63–0.83)</td>
                <td align="left" rowspan="1" colspan="1">0.86 (0.77–0.93)</td>
                <td align="left" rowspan="1" colspan="1">0.044<xref ref-type="table-fn" rid="nt110">*</xref></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Verbal memory</td>
                <td align="left" rowspan="1" colspan="1">0.86 (0.76–0.93)</td>
                <td align="left" rowspan="1" colspan="1">0.93 (0.85–0.97)</td>
                <td align="left" rowspan="1" colspan="1">0.052</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Visuospatial memory and skill</td>
                <td align="left" rowspan="1" colspan="1">0.89 (0.79–0.95)</td>
                <td align="left" rowspan="1" colspan="1">0.85 (0.76–0.92)</td>
                <td align="left" rowspan="1" colspan="1">0.539</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Attention and working memory</td>
                <td align="left" rowspan="1" colspan="1">0.65 (0.53–0.75)</td>
                <td align="left" rowspan="1" colspan="1">0.79 (0.69–0.88)</td>
                <td align="left" rowspan="1" colspan="1">0.099</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Language</td>
                <td align="left" rowspan="1" colspan="1">0.75 (0.64–0.84)</td>
                <td align="left" rowspan="1" colspan="1">0.91 (0.82–0.96)</td>
                <td align="left" rowspan="1" colspan="1">0.018<xref ref-type="table-fn" rid="nt110">*</xref></td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="nt110">
            <label>*</label>
            <p>P&lt;0.05;</p>
          </fn>
          <fn id="nt111">
            <label>**</label>
            <p>P&lt;0.01.</p>
          </fn>
          <fn id="nt112">
            <label/>
            <p>AUC: Area under curve.</p>
          </fn>
          <fn id="nt113">
            <label/>
            <p>MMSE: Mini-Mental State Examination.</p>
          </fn>
          <fn id="nt114">
            <label/>
            <p>MoCA: Montreal Cognitive Assessment.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>In screening for cognitive impairment defined as two or more cognitive domain deficits, the optimal cut-offs for the MoCA and MMSE were ≤18 and ≤24, respectively, at 2–4 weeks and ≤22 and ≤24, respectively, at 1 year (<xref ref-type="table" rid="pone-0059946-t003">Table 3</xref>), with diagnostic accuracy (% correctly classified) ranging from 80% to 92%.</p>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>The results of this study demonstrate the accuracy of the MoCA in the diagnosis of post-aSAH cognitive domain deficits and cognitive impairment at both the subacute and chronic stages. Further, they show the MoCA to be superior to the MMSE in diagnosing post-aSAH cognitive impairment at the chronic stage.</p>
      <p>Godefroy et al. recently assessed 95 patients (infarct: n = 88; haemorrhage: n = 7) to compare the efficacy of the MoCA and MMSE in detecting poststroke cognitive impairment, as determined by a neuropsychological battery, at a mean of 24 days poststroke <xref ref-type="bibr" rid="pone.0059946-Godefroy1">[13]</xref>. Both demonstrated good ability to discriminate between impaired and nonimpaired cognitive status (AUCs &gt;0.88). The MoCA performed similarly to the MMSE at an adjusted cut-off score of ≤20. These researchers’ results were similar to our observations in aSAH patients in the subacute phase.</p>
      <p>Schweizer et al. reported the first case series using the MoCA in aSAH patients. They recruited 32 aSAH patients with favourable neurological outcomes (31 good recoveries and 1 moderate disability on the Glasgow Outcome Scale) <xref ref-type="bibr" rid="pone.0059946-Schweizer1">[6]</xref>. Neurocognitive assessments were performed at least 6 months after aSAH. They found that the MMSE total score did not correlate with any neurocognitive test score except the Boston Naming Test score for language. The MoCA total score, in contrast, was correlated with the Wisconsin Card Sorting test score for executive function, Boston Naming Test score for language and California Verbal Learning test score for verbal learning and memory. They did not evaluate the relationship between the MoCA and cognitive domain deficits. The results of the current study confirm the suggested superiority of the MoCA over the MMSE in screening post-aSAH cognitive domain deficit and cognitive impairment at 1 year using a domain-specific neuropsychological assessment battery.</p>
      <p>Our optimal cut-offs (≤18 at 2–4 weeks and ≤24 at 1 year) were lower than the original cut-off (≤25) proposed by Nasreddine et al. <xref ref-type="bibr" rid="pone.0059946-Nasreddine1">[9]</xref>. One major difference between the two studies is that we were screening for cognitive impairment characterised by two or more cognitive domain deficits, whereas their focus was mild cognitive impairment. It is also possible that different language versions of the screening tools may yield different cut-off scores for the same disease entity <xref ref-type="bibr" rid="pone.0059946-Tsai1">[29]</xref> and that the nature of the disease may differ across studies.</p>
      <p>It is not known why the MoCA performed better than the MMSE in detecting cognitive impairment at the chronic stage but not the subacute stage in this study. We speculate that diffuse brain injuries significantly overshadow focal brain injuries in the manifestation of cognitive impairment at the subacute stage, whereas the reverse occurs at the chronic stage. It is recommended that biomarker studies be considered in future to investigate this interesting phenomenon.</p>
      <p>Passier et al. recently reported domain-based cognitive functioning at 3 months post-aSAH to be the most relevant independent predictor of health-related quality of life at 1 year post-aSAH <xref ref-type="bibr" rid="pone.0059946-Passier1">[30]</xref>. They also concluded that it is important to screen all patients because reduced health-related quality of life is not limited to patients discharged to a rehabilitation facility. The urgency of the need to find an optimal screening test for aSAH patients cannot be understated.</p>
      <p>MoCA’s feasibility has also been evaluated in a stroke clinical trial <xref ref-type="bibr" rid="pone.0059946-Cumming1">[31]</xref>. Of those patients who survived to 3 months, the MoCA was completed by 87% of those with mild stroke, 79% with moderate stroke and 67% with severe stroke on admission. The MoCA scale was shown to have a high degree of internal consistency, with all items loading onto a single factor that accounted for nearly half the variance. These findings further support the clinical and research application of the MoCA as a screening test for cognitive impairment in aSAH patients.</p>
      <sec id="s4a">
        <title>Limitations of This Study</title>
        <p>This study had several limitations. First, although the domain-based neuropsychological battery we used has been validated in a Chinese population with established norms, it is possible that it was insufficiently sensitive and comprehensive to measure subtle cognitive changes in patients with milder occurrences of the disease <xref ref-type="bibr" rid="pone.0059946-Scott2">[32]</xref>. Second, the cognitive domain was treated as a unitary construct rather than as a collection of different cognitive abilities. Third, undergoing the battery of cognitive assessments in addition to the MMSE and MoCA is tiring, and fatigue may have affected patients’ performance, although to compensate we offered a 5- to 10-minute rest in the middle of the assessment sessions or divided the assessments over two consecutive days. Finally, the study’s aim was to assess the cognitive profile of aSAH patients, and thus its results may not be applicable to other stroke subtypes.</p>
      </sec>
      <sec id="s4b">
        <title>Conclusion</title>
        <p>We have shown here that (1) the MoCA is able to identify cognitive impairment and cognitive domain deficits in the subacute and chronic phases of aSAH and (2) is superior to the MMSE in detecting cognitive impairment at 1 year following ictus.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pone.0059946-Chau1">
        <label>1</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chau</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Woo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Goggins</surname><given-names>WB</given-names></name>, <name name-style="western"><surname>Tse</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>KC</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Trends in stroke incidence in Hong Kong differ by stroke subtype. Cerebrovasc Dis</article-title>. <volume>31</volume>: <fpage>138</fpage>–<lpage>146</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Rinkel1">
        <label>2</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rinkel</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Algra</surname><given-names>A</given-names></name> (<year>2011</year>) <article-title>Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol</article-title>. <volume>10</volume>: <fpage>349</fpage>–<lpage>356</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-AlKhindi1">
        <label>3</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Al-Khindi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Macdonald</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Schweizer</surname><given-names>TA</given-names></name> (<year>2010</year>) <article-title>Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke</article-title>. <volume>41</volume>: <fpage>e519</fpage>–<lpage>e536</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Wong1">
        <label>4</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mok</surname><given-names>VC</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Clinical study on cognitive dysfunction after spontaneous subarachnoid haemorrhage: patient profiles and relationship to cholinergic dysfunction. Acta Neurochir</article-title>. <volume>151</volume>: <fpage>1601</fpage>–<lpage>1607</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Wong2">
        <label>5</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mok</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>WS</given-names></name> (<year>2010</year>) <article-title>Natural history and medical treatment of cognitive dysfunction after spontaneous subarachnoid haemorrhage: review of current literature with respect to aneurysm treatment. J Neurol Sci</article-title>. <volume>299</volume>: <fpage>5</fpage>–<lpage>8</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Schweizer1">
        <label>6</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schweizer</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Al-Khindi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Macdonald</surname><given-names>RL</given-names></name> (<year>2012</year>) <article-title>Mini-mental State Examination versus Montreal Cognitive Assessment: rapid assessment tools for cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. J Neurol Sci</article-title>. <volume>316</volume>: <fpage>137</fpage>–<lpage>140</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Mayer1">
        <label>7</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mayer</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Kreiter</surname><given-names>KT</given-names></name>, <name name-style="western"><surname>Copeland</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bernardini</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Bates</surname><given-names>JE</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology</article-title>. <volume>59</volume>: <fpage>1750</fpage>–<lpage>1758</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Pendlebury1">
        <label>8</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pendlebury</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Cuthbertson</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Welch</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Mehta</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Rothwell</surname><given-names>PM</given-names></name> (<year>2010</year>) <article-title>Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke. A population-based study. Stroke</article-title>. <volume>41</volume>: <fpage>1290</fpage>–<lpage>1293</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Nasreddine1">
        <label>9</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nasreddine</surname><given-names>ZS</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Bedirian</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Charbonneau</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Whitehead</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc</article-title>. <volume>53</volume>: <fpage>695</fpage>–<lpage>699</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Zadikoff1">
        <label>10</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zadikoff</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fox</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Tang-Wai</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Thomsen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>de Bie</surname><given-names>RM</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>A comparison of the Mini Mental State Exam to the Montreal Cognitive Assessment in identifying cognitive deficits in Parkinson’s disease. Movement Disorders</article-title>. <volume>23</volume>: <fpage>297</fpage>–<lpage>299</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Dong1">
        <label>11</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dong</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Venketasubramanian</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>BP</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>VK</given-names></name>, <name name-style="western"><surname>Slavin</surname><given-names>MJ</given-names></name> (<year>2012</year>) <article-title>Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3–6 months after stroke. J Neurol Neurosurg Psychiatry</article-title>. <volume>83</volume>: <fpage>580</fpage>–<lpage>585</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Wong3">
        <label>12</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ngai</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mok</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Evaluation of cognitive impairment by the Montreal Cognitive Assessment in patients with aneurysmal subarachnoid hemorrhage: prevalence, risk factors, and correlations with 3-month outcomes. J Neurol Neurosurg Psychiatry</article-title>. <volume>83</volume>: <fpage>1112</fpage>–<lpage>1117</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Godefroy1">
        <label>13</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Godefroy</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Fickl</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Roussel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Auribault</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bugnicourt</surname><given-names>JM</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke</article-title>. <volume>42</volume>: <fpage>1712</fpage>–<lpage>1716</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Wong4">
        <label>14</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>WS</given-names></name> (<year>2011</year>) <article-title>Cognitive outcome and activity of daily living for neurosurgical patients with intrinsic brain lesions: a 1-year prevalence study. Hong Kong J Occup Ther</article-title>. <volume>21</volume>: <fpage>27</fpage>–<lpage>32</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Crum1">
        <label>15</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crum</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Anthony</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Bassett</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Folstein</surname><given-names>MF</given-names></name> (<year>1993</year>) <article-title>Population-based norms for the Mini-Mental State Examination by age and education level. JAMA</article-title>. <volume>269</volume>: <fpage>2386</fpage>–<lpage>2391</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Chiu1">
        <label>16</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chiu</surname><given-names>HFK</given-names></name>, <name name-style="western"><surname>Kee</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Kwong</surname><given-names>PK</given-names></name> (<year>1994</year>) <article-title>Reliability and validity of the Cantonese version of Mini-mental State Examination – a preliminary study. J Hong Kong Coll Psychiatry</article-title>. <volume>4</volume>: <fpage>25</fpage>–<lpage>28</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Wong5">
        <label>17</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Ngai</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lam</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Mok</surname><given-names>VC</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Long-term cognitive dysfunction in patients with traumatic subarachnoid hemorrhage: prevalence and risk factors. Acta Neurochir</article-title>. <volume>154</volume>: <fpage>105</fpage>–<lpage>111</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Chan1">
        <label>18</label>
        <mixed-citation publication-type="other" xlink:type="simple">Chan AS, Kwok I (1999) Hong Kong List Learning Test: manual and preliminary norm. Hong Kong: Department of Psychological and Clinical Psychology Center.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Wechsler1">
        <label>19</label>
        <mixed-citation publication-type="other" xlink:type="simple">Wechsler D (2005) Wechsler Memory Scale III (Chinese): manual. Taiwan: Psychological Corporation.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Rey1">
        <label>20</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rey</surname><given-names>A</given-names></name> (<year>1941</year>) <article-title>L’examen psychologique dans les cas d’encephalopathie traumatique. Arch de Psychologie</article-title>. <volume>28</volume>: <fpage>296</fpage>–<lpage>302</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Smith1">
        <label>21</label>
        <mixed-citation publication-type="other" xlink:type="simple">Smith A (1982) Symbol Digit Modalities Test (SDMT) Manual. Revised ed. Los Angeles: Western Psychological Services.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Lee1">
        <label>22</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>CC</given-names></name> (<year>2000</year>) <article-title>Are trail making and color trails tests of equivalent constructs? J Clin Exp Neuropsychol</article-title>. <volume>22(4)</volume>: <fpage>529</fpage>–<lpage>34</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Chan2">
        <label>23</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>WS</given-names></name> (<year>2002</year>) <article-title>Neuropsychological sequalae of patients treated with microsurgical clipping or endovascular embolization for anterior communicating artery aneurysm. Eur Neurol</article-title>. <volume>47(1)</volume>: <fpage>37</fpage>–<lpage>44</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Tham1">
        <label>24</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tham</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Auchus</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Thong</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Goh</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>HM</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. J Neurol Sci</article-title>. <volume>203–204</volume>: <fpage>49</fpage>–<lpage>52</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Scott1">
        <label>25</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scott</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Eccles</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Molyneux</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Kerr</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Rothwell</surname><given-names>PM</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Improved cognitive outcomes with endovascular coiling of ruptured intracranial aneurysms: Neuropsychological outcomes from the International Subarachnoid Aneurysm Trial. Stroke</article-title>. <volume>41</volume>: <fpage>1743</fpage>–<lpage>1747</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-DeLong1">
        <label>26</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DeLong</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>DeLong</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Clarke-Pearson</surname><given-names>DL</given-names></name> (<year>1988</year>) <article-title>Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics</article-title>. <volume>44</volume>: <fpage>837</fpage>–<lpage>845</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Fluss1">
        <label>27</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fluss</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Faraggi</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Reiser</surname><given-names>B</given-names></name> (<year>2005</year>) <article-title>Estimation of the Youden Index and its associated cutoff point. Biom J</article-title>. <volume>47</volume>: <fpage>458</fpage>–<lpage>472</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Youden1">
        <label>28</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Youden</surname><given-names>WJ</given-names></name> (<year>1950</year>) <article-title>Index for rating diagnostic tests. Cancer</article-title>. <volume>3</volume>: <fpage>32</fpage>–<lpage>35</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Tsai1">
        <label>29</label>
        <mixed-citation publication-type="other" xlink:type="simple">Tsai CF, Lee WJ, Wang SJ, Shia BC, Nasreddine Z, <etal>et al</etal>.. (2011) Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscale validation of the Taiwanese version of the MoCA and an item response theory analysis. Int Psychogeriatr. 2011 Dec 12: 1–8 [Epub ahead of print].</mixed-citation>
      </ref>
      <ref id="pone.0059946-Passier1">
        <label>30</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Passier</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Visser-Meily</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>van Zandovoort</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Rinkel</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Lindeman</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Predictors of long-term health-related quality of life in patients with aneurysmal subarachnoid hemorrhage. Neurorehabilitation</article-title>. <source>2012</source> <volume>30</volume>: <fpage>137</fpage>–<lpage>145</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Cumming1">
        <label>31</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cumming</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>Bernhardt</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Linden</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>The Montreal Cognitive Assessment. Short cognitive evaluation in a large stroke trial. Stroke</article-title>. <volume>42</volume>: <fpage>2642</fpage>–<lpage>2644</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059946-Scott2">
        <label>32</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scott</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Eccles</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lloyd</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Carpenter</surname><given-names>K</given-names></name> (<year>2008</year>) <article-title>From multidimensional neuropsychological outcomes to a cognitive complication rate: the International Aneurysm Trial. Trials</article-title>. <volume>9</volume>: <fpage>13</fpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>